drugset / Trial / NCT06246552
Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is Multicenter, Randomized, Double-blind, Placebo-controlled, Single-dose Study to evaluate Safety and Efficacy of JTM201 in patients with Moderate or Severe Glabellar Lines
Timeline
- Start
- 2024-10-26
- Primary completion
- 2025-06-05
- Completion
- 2025-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JTM201 | Unknown | 20 iu | Intramuscular |
Indications
No indication recorded.